KalVista Pharmaceuticals, Inc. Common Stock (KALV) is a publicly traded Healthcare sector company. As of May 20, 2026, KALV trades at $26.77 with a market cap of $1.42B and a P/E ratio of -7.25. KALV moved +0.00% today. Year to date, KALV is +73.16%; over the trailing twelve months it is +121.79%. Its 52-week range spans $7.30 to $26.85. Analyst consensus is neutral with an average price target of $29.17. Rallies surfaces KALV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KalVista Pharmaceuticals, Inc. Common Stock (KALV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KALV moved +0.00% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $26.77 |
| Market Cap | $1.42B |
| P/E Ratio | -7.25 |
| EPS | $-3.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.85 |
| 52-Week Low | $7.30 |
| Volume | 7.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-183.44M |
| Gross Margin | 0.00% |
8 analysts cover KALV: 0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $29.17.